FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1985656743> ?p ?o ?g. }

• W1985656743 endingPage "1555" @default.
• W1985656743 startingPage "1555" @default.
• W1985656743 abstract "Efficacy of brief motivational interviewing to improve adherence to inhaled corticosteroids among adult asthmatics: results from a randomized controlled pilot feasibility trial Kim L Lavoie,1–3 Gregory Moullec,1,2,4 Catherine Lemiere,2 Lucie Blais,2 Manon Labrecque,2 Marie-France Beauchesne,2 Veronique Pepin,2,4 André Cartier,2 Simon L Bacon1,2,41Montreal Behavioural Medicine Centre, 2Research Centre, Hôpital du Sacré-Cœur de Montréal – A University of Montreal Affiliated Hospital, Montréal, 3Department of Psychology, University of Quebec at Montreal (UQAM), Succursale Center-Ville, Montreal, 4Department of Exercise Science, Concordia University, Montreal, Quebec, CanadaPurpose: Daily adherence to inhaled corticosteroid (ICS) regimens is one of the most important factors linked to achieving optimal asthma control. Motivational interviewing (MI) is a client-centered communication style that focuses on enhancing intrinsic motivation to engage in appropriate self-management behaviors. MI has been shown to improve a variety of health behaviors including medication adherence in other disorders, but its efficacy for the improvement of ICS adherence in asthmatics has yet to be examined. This pilot “proof of concept” trial assessed the feasibility of MI to improve daily ICS adherence and asthma control levels in adult asthmatics.Methods: Fifty-four poorly controlled (Asthma Control Questionnaire [ACQ] score ≥1.5), highly nonadherent (filled <50% of ICS medication in the last year) adult asthmatics were recruited from the outpatient asthma clinic of a university-affiliated hospital. Participants underwent baseline assessments and were randomly assigned to MI (3×30 minutes sessions within a 6-week period, n=26) or a usual care (UC) control group (n=28). ICS adherence (% pharmacy refills) and asthma control (ACQ, Asthma Control Test [ACT]) were measured at 6 and 12 months postintervention. Mixed model repeated measure analyses for both intent-to-treat and per-protocol were used. Results were adjusted for a priori-defined covariates including baseline adherence. Patients in the MI group also reported their impressions of the intervention.Results: Six-month adjusted intent-to-treat analyses revealed a mean change in the percentage of ICS refills of 13% in the MI group vs 6% in the UC group (between group net improvement associated with MI =+6% [-12% to 24%]). Twelve-month analyses revealed a mean change in the percentage of ICS refills of 11% (MI group) vs 7% in the UC group (between group net improvement associated with MI =+3% [-11% to 18%]) representing an effect size (ES) of d=0.20 (medium). Six-month adjusted net improvement in ACQ and ACT scores between MI and control groups was -0.2 and +0.7, respectively, with improvements being even more pronounced at 12 months (ACQ =-0.5; ACT =+1.1; ES, d=0.12 and 0.18 [small], respectively). Interestingly, 6- and 12-month net improvements in asthma self-efficacy (which is specifically targeted by MI) improved by +0.4 and +0.4, respectively, with an ES of d=0.46 (marginally large). Patients in the MI group rated the intervention overwhelmingly positively in terms of usefulness, pertinence, feasibility, enjoyableness, and likelihood to change adherence behavior.Conclusion: Results suggest that a brief (90 minutes) MI intervention that targets ICS adherence can produce clinically significant improvements in adherence behavior, asthma control levels, and asthma self-efficacy in poorly controlled nonadherent asthmatics at 6 months that are maintained for 1 year, and it is well accepted by patients. Future studies including larger sample sizes, modified intervention designs (eg, MI “booster” sessions), and assessments of the extent behavior changes translate into clinical improvements (eg, in asthma control and quality of life) are warranted.Keywords: motivational interviewing, asthma, adherence, inhaled corticosteroids, asthma control" @default.
• W1985656743 created "2016-06-24" @default.
• W1985656743 creator A5014286365 @default.
• W1985656743 creator A5020657977 @default.
• W1985656743 creator A5021890524 @default.
• W1985656743 creator A5036156577 @default.
• W1985656743 creator A5046872842 @default.
• W1985656743 creator A5051621018 @default.
• W1985656743 creator A5071840675 @default.
• W1985656743 creator A5088405436 @default.
• W1985656743 creator A5091305347 @default.
• W1985656743 date "2014-11-01" @default.
• W1985656743 modified "2023-10-15" @default.
• W1985656743 title "Efficacy of brief motivational interviewing to improve adherence to inhaled corticosteroids among adult asthmatics: results from a randomized controlled pilot feasibility trial" @default.
• W1985656743 cites W1528805563 @default.
• W1985656743 cites W1594166692 @default.
• W1985656743 cites W1829345793 @default.
• W1985656743 cites W1966718625 @default.
• W1985656743 cites W1983463235 @default.
• W1985656743 cites W1992513419 @default.
• W1985656743 cites W1997314662 @default.
• W1985656743 cites W2003292549 @default.
• W1985656743 cites W2008227993 @default.
• W1985656743 cites W2013410639 @default.
• W1985656743 cites W2018086889 @default.
• W1985656743 cites W2020649530 @default.
• W1985656743 cites W2028918293 @default.
• W1985656743 cites W2030139369 @default.
• W1985656743 cites W2031374777 @default.
• W1985656743 cites W2031756259 @default.
• W1985656743 cites W2036588559 @default.
• W1985656743 cites W2037776127 @default.
• W1985656743 cites W2038788137 @default.
• W1985656743 cites W2040535455 @default.
• W1985656743 cites W2043108275 @default.
• W1985656743 cites W2049321668 @default.
• W1985656743 cites W2052869732 @default.
• W1985656743 cites W2061415123 @default.
• W1985656743 cites W2062909801 @default.
• W1985656743 cites W2072879374 @default.
• W1985656743 cites W2074714879 @default.
• W1985656743 cites W2076609775 @default.
• W1985656743 cites W2077425014 @default.
• W1985656743 cites W2083047876 @default.
• W1985656743 cites W2086167722 @default.
• W1985656743 cites W2086720822 @default.
• W1985656743 cites W2103016637 @default.
• W1985656743 cites W2107122426 @default.
• W1985656743 cites W2109927751 @default.
• W1985656743 cites W2110143000 @default.
• W1985656743 cites W2111609315 @default.
• W1985656743 cites W2111871980 @default.
• W1985656743 cites W2113033841 @default.
• W1985656743 cites W2122677385 @default.
• W1985656743 cites W2123277906 @default.
• W1985656743 cites W2129778036 @default.
• W1985656743 cites W2133984342 @default.
• W1985656743 cites W2142461059 @default.
• W1985656743 cites W2147581820 @default.
• W1985656743 cites W2148583736 @default.
• W1985656743 cites W2148894790 @default.
• W1985656743 cites W2155441883 @default.
• W1985656743 cites W2157156054 @default.
• W1985656743 cites W2159371369 @default.
• W1985656743 cites W2160662817 @default.
• W1985656743 cites W2395265042 @default.
• W1985656743 cites W2406419384 @default.
• W1985656743 cites W2604596332 @default.
• W1985656743 cites W2616424562 @default.
• W1985656743 cites W2746562707 @default.
• W1985656743 cites W4199104 @default.
• W1985656743 cites W4242282959 @default.
• W1985656743 cites W74882665 @default.
• W1985656743 doi "https://doi.org/10.2147/ppa.s66966" @default.
• W1985656743 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4231985" @default.
• W1985656743 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25422587" @default.
• W1985656743 hasPublicationYear "2014" @default.
• W1985656743 type Work @default.
• W1985656743 sameAs 1985656743 @default.
• W1985656743 citedByCount "39" @default.
• W1985656743 countsByYear W19856567432013 @default.
• W1985656743 countsByYear W19856567432015 @default.
• W1985656743 countsByYear W19856567432016 @default.
• W1985656743 countsByYear W19856567432017 @default.
• W1985656743 countsByYear W19856567432018 @default.
• W1985656743 countsByYear W19856567432019 @default.
• W1985656743 countsByYear W19856567432020 @default.
• W1985656743 countsByYear W19856567432021 @default.
• W1985656743 countsByYear W19856567432022 @default.
• W1985656743 countsByYear W19856567432023 @default.
• W1985656743 crossrefType "journal-article" @default.
• W1985656743 hasAuthorship W1985656743A5014286365 @default.
• W1985656743 hasAuthorship W1985656743A5020657977 @default.
• W1985656743 hasAuthorship W1985656743A5021890524 @default.
• W1985656743 hasAuthorship W1985656743A5036156577 @default.
• W1985656743 hasAuthorship W1985656743A5046872842 @default.
• W1985656743 hasAuthorship W1985656743A5051621018 @default.
• W1985656743 hasAuthorship W1985656743A5071840675 @default.

• next